New Key Statistics Module, Z-Score and F-Score
NAS:BDRX Key Ratios
| Market Cap $ M | 5.56 |
| Enterprise Value $ M | -1.44 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.91 |
| Price/Sales | 0.78 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -405.53 |
| Beneish M-Score | 98.82 |
| 10-y EBITDA Growth Rate % | 42.10 |
| 5-y EBITDA Growth Rate % | 53.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.16 |
| EV-to-EBITDA | 0.17 |
| PEG | -- |
| Shares Outstanding M | 4.38 |
| Net Margin (%) | -1,858.01 |
| Operating Margin % | -2,103.41 |
| Pre-tax Margin (%) | -1,964.57 |
| Quick Ratio | 1.26 |
| Current Ratio | 1.26 |
| ROA % (ttm) | -88.38 |
| ROE % (ttm) | -161.63 |
| ROIC % (ttm) | -215.44 |
| Dividend Yield % | -- |
| Altman Z-Score | -20.97 |
BDRX Number of Guru Trades
BDRX Volume of Guru Trades
Gurus Latest Trades with NAS:BDRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BDRX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Biodexa Pharmaceuticals Plc Insider Transactions
No Available Data
News about NAS:BDRX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers